ArticleBMC sports science, medicine & rehabilitation2026
The effects of integrative neuromuscular training on injury risk and athletic performance in athletes: a systematic review and meta-analysis.
Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntegrative Neuromuscular Training (INT) is a multi-component training approach aimed at optimizing neuromuscular function, improving athletic performance, and reducing injury-related risks. While existing studies suggest that INT can improve injury risk factors and enhance performance, its effectiveness and underlying mechanisms remain contentious, with many existing studies lacking comprehensive quantitative synthesis and subgroup analyses.
methodsA systematic search was conducted across nine databases from their inception to August 31, 2025, for randomized controlled trials (RCTs) on the application of INT in athletes. The Cochrane Risk of Bias Assessment Tool (ROB2) was used for quality assessment. Meta-analysis was performed using Stata/MP 17.0, with risk ratios (RR) for dichotomous outcomes and standardized mean differences (SMD) for continuous outcomes. Hedges' g and 95% confidence intervals (CI) were calculated for effect sizes, and publication bias was assessed using funnel plots and Begg's and Egger's tests. The GRADE method was employed to assess the quality of evidence.
resultsA total of 25 RCTs (10,124 participants) were included. The meta-analysis revealed that INT is associated with a reduced injury risk in athletes (RR = 0.73, 95% CI: 0.58-0.91, p = 0.004), as well as improvements in jump performance (SMD = 0.88, 95% CI: 0.58-1.17, p < 0.001), sprinting ability (SMD = 0.75, 95% CI: 0.44-1.06, p < 0.001), change-of-direction ability (SMD = 0.97, 95% CI: 0.38-1.57, p = 0.001), and dynamic balance (SMD = 0.91, 95% CI: 0.31-1.51, p = 0.003), However, significant heterogeneity was found in most studies, and according to ROB2, the majority of studies were categorized as "having some concerns". Therefore, the certainty of the evidence should be interpreted in the context of the GRADE framework. Subgroup analysis suggests that INT may be particularly effective in adult athletes (≥ 18 years), female athletes, football players, and those undergoing high-frequency (≥ 3 sessions/week) and longer-duration (single session > 30 min) interventions.
conclusionCurrent evidence suggests that INT is associated with reduced injury risk and improvements in jump performance, sprinting, change-of-direction, and dynamic balance in athletes. Adult athletes, female athletes, and football players may benefit more significantly from INT, especially when the intervention frequency is ≥ 3 sessions per week and the duration exceeds 30 min per session. This study has been prospectively registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number: CRD420251131811) and was reported in strict adherence to the PRISMA 2020 guidelines. The complete PRISMA flowchart and relevant details can be found in the supplementary materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.